Scientific article
English

The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents

Published inInternational journal of cardiology, vol. 168, no. 2, p. 1466-1471
Publication date2013
Abstract

We aimed to assess the cost effectiveness of the sirolimus-eluting stent (SES) in diabetic and non-diabetic patients vs. bare metal stents (BMS).

Keywords
  • Aged
  • Cohort Studies
  • Cost-Benefit Analysis/methods/trends
  • Drug-Eluting Stents/economics/trends
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Metals/economics
  • Middle Aged
  • Myocardial Revascularization/economics/trends
  • Registries
  • Risk Factors
  • Stents/economics/trends
Citation (ISO format)
BARONE-ROCHETTE, Gilles et al. The favorable price evolution between bare metal stents and drug eluting stents increases the cost effectiveness of drug eluting stents. In: International journal of cardiology, 2013, vol. 168, n° 2, p. 1466–1471. doi: 10.1016/j.ijcard.2012.12.054
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0167-5273
577views
0downloads

Technical informations

Creation24/11/2014 15:05:00
First validation24/11/2014 15:05:00
Update14/03/2023 22:20:49
Status update14/03/2023 22:20:48
Last indexation30/10/2024 21:02:28
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack